Topic: vaccine development
Right on the heels of last week's deal in Lassa fever, CEPI has awarded IDT Biologika up to $36 million for MERS research.
Profectus’ Lassa candidate is based on its VesiculoVax vaccine delivery platform, which uses vesicular stomatitis virus as vector.
GSK, Merck, Sanofi, Pfizer and Seqirus topped the world's biggest vaccine companies list by 2017 revenue.
Johnson & Johnson's "mosaic" HIV vaccine regimen elicited immune responses one year after the final shot.